The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Spinocerebellar Degenerations

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Spinocerebellar Degenerations


Psychiatry related information on Spinocerebellar Degenerations


High impact information on Spinocerebellar Degenerations


Chemical compound and disease context of Spinocerebellar Degenerations


Biological context of Spinocerebellar Degenerations


Anatomical context of Spinocerebellar Degenerations


Gene context of Spinocerebellar Degenerations


Analytical, diagnostic and therapeutic context of Spinocerebellar Degenerations


  1. Genes involved in hereditary ataxias. Klockgether, T., Evert, B. Trends Neurosci. (1998) [Pubmed]
  2. Effect of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration. Sobue, I., Yamamoto, H., Konagaya, M., Iida, M., Takayanagi, T. Lancet (1980) [Pubmed]
  3. Molecular features of the CAG repeats of spinocerebellar ataxia 6 (SCA6). Matsuyama, Z., Kawakami, H., Maruyama, H., Izumi, Y., Komure, O., Udaka, F., Kameyama, M., Nishio, T., Kuroda, Y., Nishimura, M., Nakamura, S. Hum. Mol. Genet. (1997) [Pubmed]
  4. Failure to detect abnormal fatty acid profiles in serum lipoproteins in Friedreich's ataxia. Walker, J.L., Chamberlain, S., Robinson, N. Ann. Neurol. (1980) [Pubmed]
  5. February 2001: A 74 year old man with a history over 3 months of increasing dyspnea and malaise. Baldwin, L., Poller, D., Ellison, D. Brain Pathol. (2001) [Pubmed]
  6. Molecular genetics, recombinant DNA techniques, and genetic neurological disease. Rosenberg, R.N. Ann. Neurol. (1984) [Pubmed]
  7. Disease-associated mutations inactivate AMP-lysine hydrolase activity of Aprataxin. Seidle, H.F., Bieganowski, P., Brenner, C. J. Biol. Chem. (2005) [Pubmed]
  8. A study of certain traits accompanying some inherted neurological disorders. Skre, H. Clin. Genet. (1975) [Pubmed]
  9. No association between apolipoprotein E alleles and olivopontocerebellar atrophy. Toji, H., Kawakami, H., Kawarai, T., Nakayama, T., Komure, O., Kuno, S., Nakamura, S. J. Neurol. Sci. (1998) [Pubmed]
  10. Neuro-otological findings in a case of Marinesco-Sjögren syndrome with nystagmus. Yoshimoto, Y. Auris, nasus, larynx. (1987) [Pubmed]
  11. The gene for Machado-Joseph disease maps to human chromosome 14q. Takiyama, Y., Nishizawa, M., Tanaka, H., Kawashima, S., Sakamoto, H., Karube, Y., Shimazaki, H., Soutome, M., Endo, K., Ohta, S. Nat. Genet. (1993) [Pubmed]
  12. Spinocerebellar degeneration associated with a selective defect of vitamin E absorption. Harding, A.E., Matthews, S., Jones, S., Ellis, C.J., Booth, I.W., Muller, D.P. N. Engl. J. Med. (1985) [Pubmed]
  13. TRH and spinocerebellar degeneration. LeWitt, P.A., Ehrenkranz, J.R. Lancet (1982) [Pubmed]
  14. Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia. Chen, D.H., Brkanac, Z., Verlinde, C.L., Tan, X.J., Bylenok, L., Nochlin, D., Matsushita, M., Lipe, H., Wolff, J., Fernandez, M., Cimino, P.J., Bird, T.D., Raskind, W.H. Am. J. Hum. Genet. (2003) [Pubmed]
  15. Random search for shared chromosomal regions in four affected individuals: the assignment of a new hereditary ataxia locus. Nikali, K., Suomalainen, A., Terwilliger, J., Koskinen, T., Weissenbach, J., Peltonen, L. Am. J. Hum. Genet. (1995) [Pubmed]
  16. Mitochondrial hydroxyapatite deposits in spinocerebellar degeneration. Munoz, D.G., Emery, E.S., Highland, R.A. Ann. Neurol. (1987) [Pubmed]
  17. Spinocerebellar degeneration with parkinsonian features: a clinical and pathological report. Weir, R.L., Fan, K.J. Ann. Neurol. (1981) [Pubmed]
  18. Galactosylceramide lipidosis: novel presentation as a slowly progressive spinocerebellar degeneration. Thomas, P.K., Halpern, J.P., King, R.H., Patrick, D. Ann. Neurol. (1984) [Pubmed]
  19. An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene. Ristow, M., Giannakidou, E., Hebinck, J., Busch, K., Vorgerd, M., Kotzka, J., Knebel, B., Mueller-Berghaus, J., Epplen, C., Pfeiffer, A., Kahn, C.R., Doria, A., Krone, W., Mueller-Wieland, D. Diabetes (1998) [Pubmed]
  20. Pyruvate dehydrogenase deficiency in spinocerebellar degenerations. Kark, R.A., Rodriguez-Budelli, M. Neurology (1979) [Pubmed]
  21. Absence of REM and altered NREM sleep in patients with spinocerebellar degeneration and slow saccades. Osorio, I., Daroff, R.B. Ann. Neurol. (1980) [Pubmed]
  22. The role of the SCA2 trinucleotide repeat expansion in 89 autosomal dominant cerebellar ataxia families. Frequency, clinical and genetic correlates. Giunti, P., Sabbadini, G., Sweeney, M.G., Davis, M.B., Veneziano, L., Mantuano, E., Federico, A., Plasmati, R., Frontali, M., Wood, N.W. Brain (1998) [Pubmed]
  23. Mice lacking phosphatidylinositol transfer protein-alpha exhibit spinocerebellar degeneration, intestinal and hepatic steatosis, and hypoglycemia. Alb, J.G., Cortese, J.D., Phillips, S.E., Albin, R.L., Nagy, T.R., Hamilton, B.A., Bankaitis, V.A. J. Biol. Chem. (2003) [Pubmed]
  24. Hereditary spastic paraplegia and hereditary ataxia, Part 2: A family demonstrating various phenotypic manifestations with the SCA3 genotype. Landau, W.M., Schmidt, R.E., McGlennen, R.C., Reich, S.G. Arch. Neurol. (2000) [Pubmed]
  25. Peripheral neuropathy in spinocerebellar degenerations. McLeod, J.G., Evans, W.A. Muscle Nerve (1981) [Pubmed]
  26. Late-onset nonketotic hyperglycinemia and spinocerebellar degeneration. Steiman, G.S., Yudkoff, M., Berman, P.H., Blazer-Yost, B., Segal, S. J. Pediatr. (1979) [Pubmed]
  27. Paradoxical absence of nuclear inclusion in cerebellar Purkinje cells of hereditary ataxias linked to CAG expansion. Koyano, S., Iwabuchi, K., Yagishita, S., Kuroiwa, Y., Uchihara, T. J. Neurol. Neurosurg. Psychiatr. (2002) [Pubmed]
  28. Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis. Kwak, S., Kawahara, Y. J. Mol. Med. (2005) [Pubmed]
  29. Ataxic variant of adrenoleukodystrophy: MRI and CT findings. Kusaka, H., Imai, T. J. Neurol. (1992) [Pubmed]
  30. Dynamic expression of Hsp27 in the presence of mutant ataxin-3. Chang, W.H., Cemal, C.K., Hsu, Y.H., Kuo, C.L., Nukina, N., Chang, M.H., Hu, H.T., Li, C., Hsieh, M. Biochem. Biophys. Res. Commun. (2005) [Pubmed]
  31. Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6). Khan, N.L., Giunti, P., Sweeney, M.G., Scherfler, C., Brien, M.O., Piccini, P., Wood, N.W., Lees, A.J. Mov. Disord. (2005) [Pubmed]
  32. Diagnostic issues in a family with late onset type 2 neurofibromatosis. Evans, D.G., Bourn, D., Wallace, A., Ramsden, R.T., Mitchell, J.D., Strachan, T. J. Med. Genet. (1995) [Pubmed]
  33. Partially deficient glutamate dehydrogenase activity and attenuated oscillatory potentials in patients with spinocerebellar degeneration. Abe, T., Ishiguro, S., Saito, H., Kiyosawa, M., Tamai, M. Invest. Ophthalmol. Vis. Sci. (1992) [Pubmed]
  34. Corneal endothelial degeneration in dentatorubral-pallidoluysian atrophy. Ito, D., Yamada, M., Kawai, M., Usui, T., Hamada, J., Fukuuchi, Y. Arch. Neurol. (2002) [Pubmed]
  35. A 17th-century founder gives rise to a large north American pedigree of autosomal dominant spinocerebellar ataxia not linked to the SCA1 locus on chromosome 6. Lazzarini, A., Zimmerman, T.R., Johnson, W.G., Duvoisin, R.C. Neurology (1992) [Pubmed]
  36. Normal cerebellar glutamate dehydrogenase protein in spinocerebellar degeneration. Rosenberg, R.N., Banner, C. J. Neurol. Neurosurg. Psychiatr. (1989) [Pubmed]
  37. Effect of intranasal administration of thyrotropin-releasing hormone on ataxic gait in staggerer mice. Matsui, K., Itoh, K., Mizumachi, M., Kubo, H., Goto, T., Sato, S., Wada, K. Neurosci. Lett. (1996) [Pubmed]
WikiGenes - Universities